ArticlePediatric research2026
Personal variation in the palatability and side effects of liquid clindamycin among children.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo assess a framework for pediatric medication acceptance evaluation while measuring variability in the taste of liquid clindamycin and the occurrence of side effects.
methodsChildren receiving their first clindamycin prescription and a caregiver participated in a prospective cohort study. After practicing using the hedonic-face scale to rate water, we videotaped children rating clindamycin palatability immediately, 5-, and 10-min post-swallow. Recordings were coded for behavioral responses. Caregivers rated children's acceptance on test day and at treatment end and completed daily diaries and an exit interview on adherence, side effects, and clinical outcomes. Genome-wide genotyping probed whether genetic ancestry and selected candidate genetic variants were associated with taste ratings and side effects.
resultsWhile only 2% (1/67) disliked water, 54% (36/67) disliked the taste of clindamycin immediately post-swallow and were more likely to display facial expressions of distaste (p < 0.001). Child and caregiver ratings moderately agreed (κ = 0.51). Side effects occurred in 36% (24/67) of children. Hedonic ratings and side effects did not differ significantly by genetic ancestry or associate with TAS2R38 rs713598 or TRPA1 rs11988795 genotypes.
conclusionThis study highlights substantial variability in pediatric medicine palatability and side effects and introduces a validated framework for assessing individual differences. IMPACT: We developed a validated framework to document individual differences in medication palatability, side effects, and caregiver perceptions and practices in both remote and onsite settings. There was substantial variability in hedonic ratings of palatability and side effects of clindamycin used for standard of care treatment in children. Hedonic ratings and side effects did not differ significantly by genetic ancestry or associate with TAS2R38 rs713598 or TRPA1 rs11988795 genotypes. We introduce a new framework for assessing individual differences in palatability for liquid pediatric medicines.
Identifiers
42162282What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.